Prothena Corporation plc
PRTA
$9.17
-$0.04-0.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -92.83% | -91.16% | -95.24% | 54.55% | 47.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -92.83% | -91.16% | -95.24% | 54.55% | 47.92% |
| Cost of Revenue | -39.40% | -27.24% | -20.38% | -12.80% | 0.88% |
| Gross Profit | -43.28% | -57.26% | -652.14% | 52.69% | 32.38% |
| SG&A Expenses | -11.62% | -5.49% | -0.09% | 2.70% | 8.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -32.95% | -22.38% | -15.96% | -9.47% | 2.59% |
| Operating Income | -19.41% | -32.15% | -172.55% | 35.90% | 19.09% |
| Income Before Tax | -55.77% | -70.48% | -326.21% | 37.42% | 19.66% |
| Income Tax Expenses | 753.52% | 607.58% | 493.78% | 56.07% | 50.79% |
| Earnings from Continuing Operations | -99.57% | -112.74% | -494.87% | 36.04% | 16.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -99.57% | -112.74% | -494.87% | 36.04% | 16.81% |
| EBIT | -19.41% | -32.15% | -172.55% | 35.90% | 19.09% |
| EBITDA | -19.52% | -32.36% | -174.43% | 36.04% | 19.17% |
| EPS Basic | -99.35% | -112.23% | -492.98% | 36.41% | 17.84% |
| Normalized Basic EPS | -32.29% | -46.50% | -271.98% | 37.78% | 20.64% |
| EPS Diluted | -97.42% | -110.32% | -461.97% | 36.29% | 17.90% |
| Normalized Diluted EPS | -30.76% | -44.94% | -254.91% | 37.46% | 20.42% |
| Average Basic Shares Outstanding | 0.11% | 0.17% | 0.26% | 0.53% | 1.05% |
| Average Diluted Shares Outstanding | -0.48% | -0.42% | -2.35% | -0.93% | -0.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |